However, if you are still losing weight steadily and feel good at your current dose, there is no urgent need to increase
If we can make the atrium a less favorable environment for AFib, ablation has a better chance to work. Next Steps: Larger Trials and Broader Applications of GLP1 Therapy While LEAF was a relatively small, singlecenter study, the magnitude of benefit observed has generated interest in larger trials to confirm the findings and determine optimal timing and duration of GLP1 therapy
doi: 10.1016/J.JEP.2013.08.013 134 JinXZhangZHLiSLSunETanXBSongJet al
"The data-driven studies demonstrate about 37% of lost weight is regained in a year, but that can be very variable," Dr
Gastroenterology 132 (1), 397414
Scand J Gastroenterol (1983) 18(7):84552.10.3109/00365528309182104 166 El-SalhyMDanielssonAStenlingRGrimeliusL